Showing 1 - 14 results of 14 for search 'David M. Jablons', query time: 0.05s Refine Results
  1. 1
    The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)

    The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC) by Ping-Chih Hsu, Cheng-Ta Yang, David M. Jablons, Liang You

    Published 2020-05-01
    Get full text
    Article
  2. 2
    The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer

    The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer by Ping-Chih Hsu, Cheng-Ta Yang, David M. Jablons, Liang You

    Published 2018-12-01
    Get full text
    Article
  3. 3
    Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models

    Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models by P. Jonathan Li, Jeroen P. Roose, David M. Jablons, Johannes R. Kratz

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Central Airway Obstruction Due to Tracheal Glomus Tumor

    Central Airway Obstruction Due to Tracheal Glomus Tumor by Greg J. Haro, Eric J. Seeley, David M. Jablons, Johannes R. Kratz

    Published 2018-01-01
    Get full text
    Article
  5. 5
    2460

    2460 by Sue Wang, Gavitt A. Woodard, Calixto-Hope Lucas, Stanley J. Rogers, David M. Jablons

    Published 2017-09-01
    Get full text
    Article
  6. 6
    SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.

    SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer. by Natalie S Lui, Yi-Wei Yang, Annemieke van Zante, Petra Buchanan, David M Jablons, Hassan Lemjabbar-Alaoui

    Published 2016-01-01
    Get full text
    Article
  7. 7
    PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer

    PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer by Yang WANG, Zhidong XU, Jian-Hua MAO, David.HSIEH, Alfred AU, David M. JABLONS, Hui LI, Liang YOU

    Published 2015-06-01
    Get full text
    Article
  8. 8
    A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells

    A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells by Biao He, Liang You, Kazutsugu Uematsu, Zhidong Xu, Amie Y. Lee, Maria Matsangou, Frank McCormick, David M. Jablons

    Published 2004-01-01
    Get full text
    Article
  9. 9
    287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers

    287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers by P. Jonathan Li, Jessica Tsui, Vivianne W. Ding, Alexis J. Combes, Matthew F. Krummel, David M. Jablons, Johannes R. Kratz

    Published 2023-04-01
    Get full text
    Article
  10. 10
    Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.

    Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. by Shulin Zhang, Yucheng Wang, Jian-Hua Mao, David Hsieh, Il-Jin Kim, Li-Min Hu, Zhidong Xu, Hao Long, David M Jablons, Liang You

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10

    Cul4A Modulates Invasion and Metastasis of Lung Cancer through Regulation of ANXA10 by Ming-Szu Hung, Yi-Chuan Chen, Paul-Yann Lin, Ya-Chin Li, Chia-Chen Hsu, Jr-Hau Lung, Liang You, Zhidong Xu, Jian-Hua Mao, David M. Jablons, Cheng-Ta Yang

    Published 2019-05-01
    Get full text
    Article
  12. 12
    Genetic and immunologic features of recurrent stage I lung adenocarcinoma

    Genetic and immunologic features of recurrent stage I lung adenocarcinoma by Johannes R. Kratz, Jack Z. Li, Jessica Tsui, Jen C. Lee, Vivianne W. Ding, Arjun A. Rao, Michael J. Mann, Vincent Chan, Alexis J. Combes, Matthew F. Krummel, David M. Jablons

    Published 2021-12-01
    Get full text
    Article
  13. 13
    EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.

    EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. by Dongsheng Yue, Hui Li, Juanjuan Che, Yi Zhang, Bhairavi Tolani, Minli Mo, Hua Zhang, Qingfeng Zheng, Yue Yang, Runfen Cheng, Joy Q Jin, Thomas W Luh, Cathryn Yang, Hsin-Hui K Tseng, Etienne Giroux-Leprieur, Gavitt A Woodard, Xishan Hao, Changli Wang, David M Jablons, Biao He

    Published 2015-01-01
    Get full text
    Article
  14. 14
    NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

    NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer by Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas, Saurabh Asthana, Jenny Jiacheng Yan, Irena Tan, Gorjan Hrustanovic, Elton Chan, Luping Lin, Dana S. Neel, William Newton, Kathryn L. Bobb, Timothy R. Fouts, Jeffrey Meshulam, Matthew A. Gubens, David M. Jablons, Jeffrey R. Johnson, Sourav Bandyopadhyay, Nevan J. Krogan, Trever G. Bivona

    Published 2015-04-01
    Get full text
    Article

Search Tools: